Implementation of an adapted perioperative ventriculoperitoneal shunting protocol in a tertiary center located in a low-to-middle-income country.
Cerebrospinal fluid
Clinical protocols
Hydrocephalus
Shunt infection
Ventriculoperitoneal shunt
Journal
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
ISSN: 1433-0350
Titre abrégé: Childs Nerv Syst
Pays: Germany
ID NLM: 8503227
Informations de publication
Date de publication:
01 Apr 2024
01 Apr 2024
Historique:
received:
25
02
2024
accepted:
20
03
2024
medline:
1
4
2024
pubmed:
1
4
2024
entrez:
1
4
2024
Statut:
aheadofprint
Résumé
Preventative protocols have efficaciously reduced shunt infection in developed countries. However, the generalizability of these protocols in low-to-middle-income countries (LMICs) remains unclear. Previously, shunt insertion in the authors' center was routinely performed under institutional preventative precautions, which was updated via merging with the Hydrocephalus Clinical Research Network (HCRN) protocol. This study aimed to investigate the ventriculoperitoneal shunt (VPS) infection rates in pediatric patients following the implementation of the adapted protocol. The adapted protocol was implemented in all first-time VPS implantations between 2011 and 2021. The primary outcome was a 6-month shunt infection. The Pearson chi-square test was used for categorical variables and the Mann-Whitney U-test for numeric variables to evaluate the correlation with shunt infection. A total of 352 first-time VPS procedures were performed adhering to the adapted protocol. The median age was 5 months, and 189 (53.7%) were male. Overall, 37 patients (10.5%) experienced shunt infection, with 30 (8.5%) occurring within the first 6 months, which was lower than 13.3% infection rate of the previous series of the same center. The infection rate was slightly higher than the 5.7% and 6.0% rates reported by HCRN studies. Patients with shunt infection were significantly younger (7.5 versus 17.5 months, P < 0.001). This study validates the efficacy of an adapted perioperative protocol in mitigating shunt infection in a high-volume center in a LMIC. Adhering to a step-by-step protocol, modified to suit the healthcare resources and financial constraints of LMICs, could maintain low shunt infection rates that are roughly comparable to those of centers in high-income countries.
Identifiants
pubmed: 38557895
doi: 10.1007/s00381-024-06374-z
pii: 10.1007/s00381-024-06374-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Simon TD, Butler J, Whitlock KB, Browd SR, Holubkov R, Kestle JR, Kulkarni AV, Langley, Limbrick Jr DD, Mayer-Hamblett N, Tamber M (2014) Risk factors for first cerebrospinal fluid shunt infection: findings from a multi-center prospective cohort study. J Pediatr 164:1462–1468
pubmed: 24661340
pmcid: 4035376
doi: 10.1016/j.jpeds.2014.02.013
Tamber MS, Klimo P, Mazzola CA, Flannery AM (2014) Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 8: Management of cerebrospinal fluid shunt infection. J Neurosurg Pediatr 14:60–71
pubmed: 25988784
doi: 10.3171/2014.7.PEDS14328
González S, Carbonaro M, Fedullo AG, Sormani MI, Ceinos MD, Biochemistb RG, Rosanova MT (2018) Cerebrospinal fluid shunt-associated infections in pediatrics: Analysis of the epidemiology and mortality risk factors. Arch Argent Pediatr 116:198–203
pubmed: 29756704
Vinchon M, Dhellemmes P (2006) Cerebrospinal fluid shunt infection: risk factors and long-term follow-up. Childs Nerv Syst 22:692–697
pubmed: 16534646
doi: 10.1007/s00381-005-0037-8
Sciubba DM, Lin L-M, Woodworth GF, McGirt MJ, Carson B, Jallo GI (2007) Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic-impregnated components. Neurosurg Focus 22:1–4
doi: 10.3171/foc.2007.22.4.11
Kestle JR, Garton HJ, Whitehead WE, Drake JM, Kulkarni AV, Cochrane DD, Muszynski C, Walker ML (2006) Management of shunt infections: a multicenter pilot study. J Neurosurg Pediatr 105:177–181
doi: 10.3171/ped.2006.105.3.177
Simon TD, Hall M, Dean JM, Kestle JRW, Riva-Cambrin J (2010) Reinfection following initial cerebrospinal fluid shunt infection. J Neurosurg Pediatr 6:277–285
pubmed: 20809713
pmcid: 2953872
doi: 10.3171/2010.5.PEDS09457
Simon TD, Kronman MP, Whitlock KB, Gove NE, Mayer-Hamblett N, Browd SR, Cochrane DD, Holubkov R, Kulkarni AV, Langley M (2018) Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study. J Neurosurg Pediatr 21:346–358
pubmed: 29393813
pmcid: 5880734
doi: 10.3171/2017.9.PEDS17112
Kestle JRW, Holubkov R, Cochrane DD, Kulkarni AV, Limbrick DD, Luerssen TG, Oakes WJ, Riva-Cambrin J, Rozzelle C, Simon TD (2016) A new Hydrocephalus Clinical Research Network protocol to reduce cerebrospinal fluid shunt infection. J Neurosurg Pediatr 17:391–396
pubmed: 26684763
doi: 10.3171/2015.8.PEDS15253
Kestle JRW, Riva-Cambrin J, Wellons JC, Kulkarni AV, Whitehead WE, Walker ML, Oakes WJ, Drake JM, Luerssen TG, Simon TD (2011) A standardized protocol to reduce cerebrospinal fluid shunt infection: the Hydrocephalus Clinical Research Network Quality Improvement Initiative. J Neurosurg Pediatr 8:22–29
pubmed: 21721884
pmcid: 3153415
doi: 10.3171/2011.4.PEDS10551
Omrani O, O’Connor J, Hartley J, James G (2018) Effect of introduction of a standardised peri-operative protocol on CSF shunt infection rate: a single-centre cohort study of 809 procedures. Childs Nerv Syst 34:2407–2414
pubmed: 30132097
pmcid: 6224013
doi: 10.1007/s00381-018-3953-0
Yang MMH, Hader W, Bullivant K, Brindle M, Riva-Cambrin J (2019) Calgary Shunt Protocol, an adaptation of the Hydrocephalus Clinical Research Network shunt protocol, reduces shunt infections in children. J Neurosurg Pediatr 23:559–567
doi: 10.3171/2018.10.PEDS18420
Simon TD, Riva-Cambrin J, Srivastava R, Bratton SL, Dean JM, Kestle JRW (2008) Hospital care for children with hydrocephalus in the United States: utilization, charges, comorbidities, and deaths. J Neurosurg Pediatr 1:131–137
pubmed: 18352782
doi: 10.3171/PED/2008/1/2/131
Leaper DJ, Edmiston CE (2017) World Health Organization: global guidelines for the prevention of surgical site infection. J Hosp Infect 95:135–136
pubmed: 28139389
doi: 10.1016/j.jhin.2016.12.016
Chu J, Jensen H, Holubkov R, Krieger MD, Kulkarni AV, Riva-Cambrin J, Rozzelle CJ, Limbrick DD, Wellons JC, Browd SR (2022) The Hydrocephalus Clinical Research Network quality improvement initiative: the role of antibiotic-impregnated catheters and vancomycin wound irrigation. J Neurosurg Pediatr 29:711–718
pubmed: 35303708
doi: 10.3171/2022.2.PEDS2214
Nejat F, Tajik P, Ghodsi SM, Golestan B, Majdzadeh R, Yazdani S, Ansari S, Dadmehr M, Ganji S, Najafi M (2008) Breastfeeding: a potential protective factor against ventriculoperitoneal shunt infection in young infants. J Neurosurg Pediatr 1:138–141
pubmed: 18352783
doi: 10.3171/PED/2008/1/2/138
Erps A, Roth J, Constantini S, Lerner-Geva L, Grisaru-Soen G (2018) Risk factors and epidemiology of pediatric ventriculoperitoneal shunt infection. Pediatr Int 60:1056–1061
pubmed: 30290047
doi: 10.1111/ped.13709
Choux M, Genitori L, Lang D, Lena G (1992) Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 77:875–880
pubmed: 1432129
doi: 10.3171/jns.1992.77.6.0875
Faillace WJ (1995) A no-touch technique protocol to diminish cerebrospinal fluid shunt infection. Surg Neurol 43:344–350
pubmed: 7792703
doi: 10.1016/0090-3019(95)80060-T
Pirotte BJM, Lubansu A, Bruneau M, Loqa C, Van Cutsem N, Brotchi J (2007) Sterile surgical technique for shunt placement reduces the shunt infection rate in children: preliminary analysis of a prospective protocol in 115 consecutive procedures. Childs Nerv Syst 23:1251–1261
pubmed: 17705062
doi: 10.1007/s00381-007-0415-5
Rotim K, Miklic P, Paladino J, Melada A, Marcikic M, Scap M (1997) Reducing the incidence of infection in pediatric cerebrospinal fluid shunt operations. Childs Nerv Syst 13:584–587
pubmed: 9454973
doi: 10.1007/s003810050144
Spader HS, Hertzler DA, Kestle JRW, Riva-Cambrin J (2015) Risk factors for infection and the effect of an institutional shunt protocol on the incidence of ventricular access device infections in preterm infants. J Neurosurg Pediatr 15:156–160
pubmed: 25479576
doi: 10.3171/2014.9.PEDS14215
Turner RS (1974) Laminar air flow: its original surgical application and long-term results. JBJS 56:430–435
doi: 10.2106/00004623-197456020-00028
Weiser MC, Moucha CS (2018) Operating-room airflow technology and infection prevention. JBJS 100:795–804
doi: 10.2106/JBJS.17.00852
Larsson J, Sutherland S, Söderström Å, Roman-Emanuel C, Jeppsson A, Olofsson EH, Svensson P-A (2015) Bacterial contamination of suction catheter tips during aortic valve replacement surgery: a prospective observational cohort study. Patient Saf Surg 9:1–5
doi: 10.1186/s13037-015-0066-5
Robinson AH, Drew S, Anderson J, Bentley G, Ridgway GL (1993) Suction tip contamination in the ultraclean-air operating theatre. Ann R Coll Surg Engl 75:254
pubmed: 8379628
pmcid: 2497922
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, Committee HICPA (1999) Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 20:247–280
doi: 10.1086/501620
Darouiche RO, Wall MJ Jr, Itani KMF, Otterson MF, Webb AL, Carrick MM, Miller HJ, Awad SS, Crosby CT, Mosier MC (2010) Chlorhexidine–alcohol versus povidone–iodine for surgical-site antisepsis. N Engl J Med 362:18–26
pubmed: 20054046
doi: 10.1056/NEJMoa0810988
Mimoz O, Lucet J-C, Kerforne T, Pascal J, Souweine B, Goudet V, Mercat A, Bouadma L, Lasocki S, Alfandari S (2015) Skin antisepsis with chlorhexidine–alcohol versus povidone iodine–alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 386:2069–2077
pubmed: 26388532
doi: 10.1016/S0140-6736(15)00244-5
Muram S, Isaacs AM, Sader N, Holubkov R, Fong A, Conly J, Hamilton MG (2022) A standardized infection prevention bundle for reduction of CSF shunt infections in adult ventriculoperitoneal shunt surgery performed without antibiotic-impregnated catheters. J Neurosurg 1:1–9
Okamura Y, Maruyama K, Fukuda S, Horikawa H, Sasaki N, Noguchi A, Nagane M, Shiokawa Y (2019) Detailed standardized protocol to prevent cerebrospinal fluid shunt infection. J Neurosurg 132:755–759
pubmed: 30771771
doi: 10.3171/2018.10.JNS181432
Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP (1992) The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 326:281–286
pubmed: 1728731
doi: 10.1056/NEJM199201303260501
Brown EM (1993) Antimicrobial prophylaxis in neurosurgery. J Antimicrob Chemother 31:49–63
pubmed: 8449846
doi: 10.1093/jac/31.suppl_B.49
Lee FH, Pfeffer M, Van Harken DR, Smyth RD, Hottendorf GH (1980) Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans. Antimicrob Agents Chemother 17:188–192
pubmed: 7387141
pmcid: 283756
doi: 10.1128/AAC.17.2.188
Gathura E, Poenaru D, Bransford R, Albright AL (2010) Outcomes of ventriculoperitoneal shunt insertion in Sub-Saharan Africa. J Neurosurg Pediatr 6:329–335
pubmed: 20887104
doi: 10.3171/2010.7.PEDS09543
Lane JD, Mugamba J, Ssenyonga P, Warf BC (2014) Effectiveness of the Bactiseal Universal Shunt for reducing shunt infection in a sub-Saharan African context: a retrospective cohort study in 160 Ugandan children. J Neurosurg Pediatr 13:140–144
pubmed: 24313655
doi: 10.3171/2013.11.PEDS13394
Warf BC (2005) Comparison of 1-year outcomes for the Chhabra and Codman-Hakim Micro Precision shunt systems in Uganda: a prospective study in 195 children. J Neurosurg Pediatr 102:358–362
doi: 10.3171/ped.2005.102.4.0358
Dallacasa P, Dappozzo A, Galassi E, Sandri F, Cocchi G, Masi M (1995) Cerebrospinal fluid shunt infections in infants. Childs Nerv Syst 11:643–649
pubmed: 8608581
doi: 10.1007/BF00300722
Forward KR, Fewer HD, Stiver HG (1983) Cerebrospinal fluid shunt infections: a review of 35 infections in 32 patients. J Neurosurg 59:389–394
pubmed: 6886752
doi: 10.3171/jns.1983.59.3.0389
McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ (2003) Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 36:858–862. https://doi.org/10.1086/368191
doi: 10.1086/368191
pubmed: 12652386
Caceres A, Avila ML, Herrera ML (2018) Fungal infections in pediatric neurosurgery. Childs Nerv Syst 34:1973–1988
pubmed: 30121829
doi: 10.1007/s00381-018-3942-3
Adams DJ, Rajnik M (2014) Microbiology and treatment of cerebrospinal fluid shunt infections in children. Curr Infect Dis Rep 16:427. https://doi.org/10.1007/s11908-014-0427-8
doi: 10.1007/s11908-014-0427-8
pubmed: 25129115
Montero A, Romero J, Vargas JA, Regueiro CA, Sanchez-Aloz G, De Prados F, De la Torre A, Aragon G (2000) Candida infection of cerebrospinal fluid shunt devices: report of two cases and review of the literature. Acta Neurochir (Wien) 142:67–74
pubmed: 10664378
doi: 10.1007/s007010050009